<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04328298</url>
  </required_header>
  <id_info>
    <org_study_id>DESCAR-T</org_study_id>
    <nct_id>NCT04328298</nct_id>
  </id_info>
  <brief_title>French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment</brief_title>
  <official_title>French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Lymphoma Academic Research Organisation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gilead Sciences</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The Lymphoma Academic Research Organisation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a registry including prospective and retrospective data on all patients who&#xD;
      have been presented in a Multidisciplinary tumor board or RCP to be eligible for CAR-T cell&#xD;
      treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 19, 2019</start_date>
  <completion_date type="Anticipated">December 19, 2038</completion_date>
  <primary_completion_date type="Anticipated">December 19, 2038</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>15 Years</target_duration>
  <primary_outcome>
    <measure>overall survival from eligibility</measure>
    <time_frame>15 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall survival from administration</measure>
    <time_frame>15 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>complete response rate</measure>
    <time_frame>15 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Progression free survival</measure>
    <time_frame>15 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of response</measure>
    <time_frame>15 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Delays between patient eligibility and CAR-T treatment</measure>
    <time_frame>15 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">1800</enrollment>
  <condition>Hematopathology Eligible or CAR-t Cell Treatment</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient eligible for a treatment with CAR-T for an hematological malignancy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Retrospective inclusion :&#xD;
&#xD;
          -  Patient treated with CAR-T from 1 July 2018 under temporary authorization (ATU) or&#xD;
             covered by French health insurance system (under post-ATU or MA) in a qualified center&#xD;
             before activation of this register in this center&#xD;
&#xD;
          -  If the patient is alive, the patient has been informed of the collection and use of&#xD;
             their data, and the patient has not opposed this use. If the patient has died, the&#xD;
             patient did not opposed the use of their data while alive&#xD;
&#xD;
        Prospective inclusion :&#xD;
&#xD;
          -  Patient eligible for a treatment with CAR-T for an hematological malignancy which is&#xD;
             covered by French health insurance (for ATUs / post-ATUs or MA), or as part of a&#xD;
             clinical trial with the same indication, after the activation of this register in this&#xD;
             center.&#xD;
&#xD;
          -  Patient whose CAR-T indication has been validated during a multidisciplinary tumor&#xD;
             board (RCP) of a qualified center, according to the ministerial order of 8 August 2019&#xD;
&#xD;
          -  Patient deemed eligible for a treatment with CAR-T after a medical exam performed in a&#xD;
             qualified center according to the ministerial order of 8 August 2019&#xD;
&#xD;
          -  If the patient is alive, the patient has been informed of the collection and use of&#xD;
             their data, and the patient has not opposed this use. If the patient has died, the&#xD;
             patient did not opposed the use of their data while alive.&#xD;
&#xD;
        Exclusion Criteria Patient not registered with the social security in France&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven LE GOUILL, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nantes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roch HOUOT, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Pontchaillou</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexia Schwartzmann</last_name>
    <phone>+33 (04) 72 66 93 33</phone>
    <email>descar-t@lysarc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU d'Amiens - Hôpital Sud</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magalie JORIS, MD</last_name>
      <phone>+33 (0)3 22 45 60 00</phone>
      <email>joris.magalie@chu-amiens.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aline TANGUY-SCHMIDT, MD</last_name>
      <email>alschmidt@chu-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU Besançon - Hôpital Minjoz</name>
      <address>
        <city>Besançon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrien CHAUCHET, MD</last_name>
      <phone>+33 (0)3 81 66 82 32</phone>
      <email>achauchet@chu-besancon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Brest - Hôpital du Morvan</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrian TEMPESCUL, MD</last_name>
      <email>adrian.tempescul@chu-brest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut d'Hématologie de Basse Normandie</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ghandi DAMAJ, Pr</last_name>
      <email>damaj-gl@chu-caen.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU d'Estaing</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacques-Olivier BAY, Pr</last_name>
      <phone>+33 (0)4 73 75 00 65</phone>
      <email>jobay@chu-clermontferrand.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP - Hôpital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabien LE BRAS, MD</last_name>
      <phone>+33 (0)1 49 83 65 05</phone>
      <email>fabien.le-bras@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier CASASNOVAS, MD</last_name>
      <phone>+33 (0)3 80 29 50 41</phone>
      <email>olivier.casasnovas@chu-dijon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>La Tronche</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvain CARRAS, MD</last_name>
      <phone>+33 (0)4 76 76 57 55</phone>
      <email>scarras@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU de Lille - Hôpital Claude Hurriez</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ibrahim YAKOUB-AGHA, Pr</last_name>
      <phone>+33 (0)3 20 44 42 84</phone>
      <email>ibrahim.yakoubagha@chru-lille.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Dupuytren</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie ABRAHAM, MD</last_name>
      <phone>+33 (0)5 55 05 66 51</phone>
      <email>julie.abraham@chu-limoges.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arthur STERIN, MD</last_name>
      <email>arthur.sterin@aph-m.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmette</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume CARTRON, Pr</last_name>
      <phone>+33(0)4 67 33 67 33</phone>
      <email>guillaume.cartron@orange.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes - Hôtel Dieu</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven LE GOUILL, Pr</last_name>
      <phone>+33 (0)2 40 08 32 71</phone>
      <email>steven.legouill@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nice</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michaël LOSCHI, MD</last_name>
      <phone>+33 (0)4 92 03 90 25</phone>
      <email>loschi.m@chu-nice.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP - Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérémie ZERBIT, Dr</last_name>
      <email>jeremie.zerbit@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP - Hôpital La Pitié Salpêtrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvain CHOQUET, MD</last_name>
      <phone>+33 (0)1 42 16 28 26</phone>
      <email>sylvain.choquet@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP - Hôpital Necker</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier HERMINE, Pr</last_name>
      <phone>+33 (0)1 44 49 51 98</phone>
      <email>olivier.hermine@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP - Hôpital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamad MOHTY, Pr</last_name>
      <phone>+33 (0)1 49 28 26 20</phone>
      <email>mohamad.mohty@inserm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP - Hôpital Saint Louis</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine THIEBLEMONT, Pr</last_name>
      <phone>+33 (0) 1 42 49 98 37</phone>
      <email>catherine.thieblemont@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP - Hôpital Universitaire Robert Debré</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>André BARUCHEL, Pr</last_name>
      <phone>+33 (0)1 40 03 53 88</phone>
      <email>andre.baruchel@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Francois Magendie</name>
      <address>
        <city>Pessac</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kamal BOUABDALLAH, MD</last_name>
      <phone>+33 (0)5 57 65 65 11</phone>
      <email>kamal.bouabdallah@chu-bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Pierre Bénite</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel BACHY, Pr</last_name>
      <phone>+33 (0)4 78 86 43 01</phone>
      <email>emmanuel.bachy@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Milétrie - CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier LELEU, Pr</last_name>
      <phone>+33 (0)5 49 44 46 89</phone>
      <email>xavier.leleu@chu-poitiers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes - Hôpital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry LAMY-DE-LA-CHAPELLE, Pr</last_name>
      <phone>+33 (0)2 99 28 42 91</phone>
      <email>thierry.lamy.de.la.chapelle@chu-rennes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Henri Becquerel</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice JARDIN, Pr</last_name>
      <phone>+33 (0)2 32 08 24 65</phone>
      <email>fabrice.jardin@chb.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ICANS (Institut de Cancérologie Strasbourg Europe)</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Blandine GUFFROY, MD</last_name>
      <email>b.guffroy@icans.eu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire du Cancer - Oncopole Toulouse (IUCT-O)</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre BORIES, MD</last_name>
      <phone>+33 (0)5 31 15 65 14</phone>
      <email>bories.pierre@iuct-oncopole.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Bretonneau</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel GYAN, MD</last_name>
      <phone>+33 (0)2 47 47 37 12</phone>
      <email>e.gyan@chu-tours.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Brabois</name>
      <address>
        <city>Vandoeuvre les Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Thérèse RUBIO, Pr</last_name>
      <phone>+33 (0)3 83 15 32 82</phone>
      <email>m.rubio@chru-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Marie-Thérèse RUBIO, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cécile POCHON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gustave Roussy Cancer Campus</name>
      <address>
        <city>Villejuif</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina CASTILLA LLORENTE, MD</last_name>
      <phone>+33 (0)1 42 11 42 39</phone>
      <email>cristina.castilla-llorente@gustaveroussy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 27, 2020</study_first_submitted>
  <study_first_submitted_qc>March 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 31, 2020</study_first_posted>
  <last_update_submitted>July 23, 2021</last_update_submitted>
  <last_update_submitted_qc>July 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

